The P2X2 receptor is an ATP-gated ion channel, assembled by three subunits. Recently, it has been found that heterozygous mutations of P2X2 V60L and G353R can cause autosomal dominant nonsyndromic hearing loss. However, the underlying mechanism remains unclear. The fact that heterozygous mutations cause deafness suggests that the mutations may have dominant-negative effect (DNE) on wild-type (WT) P2X2 isoforms and/or other partners leading to hearing loss. In this study, the effect of these dominant deafness P2X2 mutations on WT P2X2 was investigated. We found that sole transfection of both V60L and G353R deafness mutants could efficiently target to the plasma membrane, like WT P2X2, but exhibit a significantly reduced response to ATP stimulation. Both mutants reduced the channel conductance, but G353R mutation also altered the voltage dependency. Co-expression with WT P2X2 could restore the response to ATP. As the ratio of WT P2X2 vs. mutants increased, the response to ATP was also increased. Computer modeling confirmed that both V60L and G353R dominant-deafness mutant subunits do not have any negative effect on WT P2X2 subunit, when assembled as a heterotrimer. Improper docking or defective gating is the more likely mechanism for impaired channel function by these P2X2 deafness mutations. These results suggest that P2X2 dominant deafness mutations do not have negative effects on WT P2X2 isoforms, and that adding additional WT P2X2 could rescue the lost channel function caused by the deafness mutations. These P2X2 dominant deafness mutations may have negative-effects on other partners leading to hearing loss.
|Journal||Frontiers in Molecular Neuroscience|
|State||Published - Nov 13 2017|
Bibliographical noteFunding Information:
1Department of Otolaryngology, University of Kentucky Medical Center, Lexington, KY, United States, 2Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7199, Laboratoire de Conception et Application de Molécules Bioactives, Équipe de Chimie et Neurobiologie Moléculaire, Strasbourg, France, 3Faculté de Pharmacie, Université de Strasbourg, Strasbourg, France, 4Department of Otolaryngology, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China
This work was supported by NIH R01 DC 05989 and R56 DC 015019 to H-BZ and the Agence Nationale de la Recherche (ANR-14-CE11-0004-01) to TG. NY was supported by Major State Basic Research Development Program of China (No. 2014CB943002) and National Natural Science Foundation of China (No. 81470700).
© 2017 Zhu, Beudez, Yu, Grutter and Zhao.
- Dominant negative effect
- Functional restoration
- P2X2 receptor
ASJC Scopus subject areas
- Molecular Biology
- Cellular and Molecular Neuroscience